These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8127924)

  • 21. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine.
    O'Connor JE; Costell M; Grisolía S
    Biochem Biophys Res Commun; 1987 Jun; 145(2):817-24. PubMed ID: 3593373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of benzoate and hippurate on the regulation of interorgan nitrogen flow: therapeutic benefits.
    Dass PD; Stuart BP; Holmes EW
    Contrib Nephrol; 1994; 110():150-7. PubMed ID: 7956249
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of sodium benzoate on ammonia toxicity in rats.
    Maswoswe SM; Cyr DM; Griffith AD; Tremblay GC
    Biochem Biophys Res Commun; 1986 Jul; 138(1):369-73. PubMed ID: 3741416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzoate modulates renal and extrarenal nitrogen flow: metabolic mechanisms.
    Dass PD; Bautista NS; Hardman SH; Lawson LR; Kurtz I
    Life Sci; 1991; 48(8):723-31. PubMed ID: 1671610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamyl glutamate prevents the potentiation of ammonia toxicity by sodium benzoate.
    O'Connor JE; Costell M; Grisolía S
    Eur J Pediatr; 1989 Apr; 148(6):540-2. PubMed ID: 2744016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of the glycine cleavage system in hyperammonemia treated with benzoate.
    Kodama H; Fujiwara K; Motokawa Y; Tajiri H; Nose O; Kamoshita S
    Tohoku J Exp Med; 1983 Jul; 140(3):337-8. PubMed ID: 6623463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of dietary glycine and benzoate level on benzoate metabolism in mink (Mustela vision), blue fox (Alopex lagopus), and raccoon dog (Nyctereutes procyonoides).
    Pölönen IJ; Partanen KH; Jalava TK; Toivonen VF
    J Anim Sci; 2000 Apr; 78(4):976-86. PubMed ID: 10784188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of sodium benzoate to alleviate plasma and liver ammonia in rats.
    Palekar AG; Canas JA; Kalbag SS; Kim SJ; Castro-Magana M; Angulo MA
    Biochem Med Metab Biol; 1989 Feb; 41(1):64-9. PubMed ID: 2713151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
    Michalak A; Qureshi IA
    Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid in hyperammonemic patients treated with sodium benzoate.
    Shinka T; Inoue Y; Kuhara T; Matsumoto M; Matsumoto I
    Clin Chim Acta; 1985 Oct; 151(3):293-300. PubMed ID: 4053389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
    Michalak A; Qureshi IA
    Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
    del Rosario M; Werlin SL; Lauer SJ
    J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation by piridoxilate of the synthesis of hippurate from benzoate in isolated rat hepatocytes. An approach to the determination of new pathways of nitrogen excretion in inborn errors of urea synthesis.
    Coude FX; Coude M; Grimber G; Pelet A; Charpentier C
    Clin Chim Acta; 1984 Jan; 136(2-3):211-7. PubMed ID: 6692575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans.
    Kubota K; Ishizaki T
    Eur J Clin Pharmacol; 1991; 41(4):363-8. PubMed ID: 1804654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of inhibition of gluconeogenesis and ureagenesis by sodium benzoate.
    Cyr DM; Egan SG; Brini CM; Tremblay GC
    Biochem Pharmacol; 1991 Jul; 42(3):645-54. PubMed ID: 1677573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.
    Batshaw ML
    Prog Clin Biol Res; 1983; 127():69-83. PubMed ID: 6889404
    [No Abstract]   [Full Text] [Related]  

  • 39. Partial pyruvate decarboxylase deficiency with profound lactic acidosis and hyperammonemia: responses to dichloroacetate and benzoate.
    McCormick K; Viscardi RM; Robinson B; Heininger J
    Am J Med Genet; 1985 Oct; 22(2):291-9. PubMed ID: 4050860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On benzoate therapy for ammonia toxicity.
    Tremblay CC; Wendler PA
    Pediatrics; 1982 Sep; 70(3):503-4. PubMed ID: 7110831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.